Effectiveness of Rajapravartani Vati and Saraswatarishta in Dysmenorhoea - A prospective community based study - Nil

Central Council for Research in Ayurvedic Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月29日

试验速览

暂无简介。

•i.Women of age 14 -25 years with self-reported history of menstrual pain of moderate to severe nature (as per WaLIDD score) (Annexure I)
•ii.At least 3 painful cycles in last 6 cycles
•iii.Having normal menstrual cycle (21-35 days) with normal menstrual bleeding (3-7 days) during last 3 cycles
•iv.Participants willing to provide written informed consent/ assent for their participation in the study for 6 months.

•i.Irregular Cycles.
•ii.Cases of secondary Dysmenorrhea [Known case or h/o of leiomyoma of uterus, ovarian cyst, endometriosis. pelvic inflammatory disease (PID)]
•iii.Pain abdomen associated with excessive bleeding per vagina.
•iv.Presence of persistent pelvic pain throughout the menstrual cycle.
•v.Associated with any pre-diagnosed or clinically diagnosed systemic disorders likely to influence menstrual cycle.
•vi.Participants with Hb <10 gm %
•vii.History of malignancy of pelvic organs.
•viii.Diagnosed cases Hypothyroidism /hyperthyroidism
•ix.Woman using IUD / Oral Contraceptive Pills (OCP)
•x.Participants having blood pressure = 160/100 mmHg, &/or HbA1C >8 %
•xi.Participants with concurrent serious hepatic disorder (defined as Aspartate AminoTransferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin, Alkaline Phosphatase (ALP) > 2 times upper normal limit) or Renal Disorders (defined as S. Creatinine > upper normal limit)
•xii.Participants with diagnosed concurrent neurological, pulmonary or endocrine disorder, or unstable cardio-vascular disease
•xiii.Women who are planning to conceive in the next 6 months
•xiv.Lactating women
•xv.Participation in other concomitant therapy for acute or chronic pain.

发起方